Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications section now notes that items are auto-filled from PubMed. It also updates the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.1%
- Check28 days agoChange DetectedThe government funding status notice was removed from the page. The study details, contacts, and locations remain unchanged.SummaryDifference0.4%
- Check43 days agoChange DetectedNo substantive changes detected between the two screenshots. Core study details such as the title, NCT number, enrollment, and locations appear unchanged.SummaryDifference0.5%
- Check71 days agoChange DetectedMajor update: alerts about government funding status and a new version v3.2.0. Deletion of v3.1.0 indicates the version refresh.SummaryDifference3%
- Check79 days agoChange DetectedUpdate: version tag changed from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.1%
- Check93 days agoChange DetectedThe page now shows Revision: v3.0.2 instead of v3.0.1, and the Back to Top element has been removed.SummaryDifference0.2%
Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.